Collplant Biotechnologies Ltd current report, Q2 FY2019

Business Context and Reporting Period

This Form 6-K filing by CollPlant Holdings Ltd. (referred to as Collplant Biotechnologies Ltd in metadata) covers the period of May 2019. The filing serves to announce an Extraordinary General Meeting of Shareholders scheduled for June 6, 2019, in Tel-Aviv, Israel.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.

Material Changes

No material financial changes versus a prior comparable period are reported in this filing. The primary event is the scheduling of a corporate governance meeting.

Guidance, Outlook, and Management Commentary

Management has announced the convening of an Extraordinary General Meeting to vote on specific proposals. The filing includes the Notice and Proxy Statement, a Proxy Card for ordinary share holders, and a Voting Instruction Card for ADS holders. No financial guidance, risk factors, or unusual items are detailed in this specific text.

Key Facts for Investor Verification

  • Meeting Date: June 6, 2019, at 10:00 a.m. Israel time.
  • Meeting Location: Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co., Tel-Aviv, Israel.
  • Shareholders must review Exhibit 99.1 for specific proposals to be voted upon.
  • Voting can be conducted in person or by proxy using the forms provided in Exhibits 99.2 and 99.3.
  • The filing incorporates by reference into Registration Statements on Form S-8 and Form F-3.